Drug-drug interaction profile of the all-oral anti-hepatitis C virus regimen of paritaprevir/ritonavir, ombitasvir, and dasabuvir
Publication Type:
Journal Article
Authors:
Menon, Rajeev M.;
Badri, Prajakta S.;
Wang, Tianli;
Polepally, Akshanth R.;
Zha, Jiuhong;
Khatri, Amit;
Wang, Haoyu;
Hu, Beibei;
Coakley, Eoin P.;
Podsadecki, Thomas J.;
Awni, Walid M.;
Dutta, SandeepSource:
J Hepatol, Volume 63, Issue 1, p.20-29 (2015)
Keywords:
Administration, Oral,
Adolescent,
Adult,
Anilides,
Antiviral Agents,
Carbamates,
Dasabuvir,
Drug Interactions,
Drug Therapy, Combination,
Drug-drug interactions,
Female,
Hepacivirus,
Hepatitis C Antibodies,
hepatitis C virus,
Hepatitis C, Chronic,
Humans,
Macrocyclic Compounds,
Male,
Middle Aged,
Ombitasvir,
Paritaprevir,
ritonavir,
Sulfonamides,
Uracil,
Young Adult
